Covid19 Vaccine(s) specific Testing + R&D developments, page-11

13 Nov'20 - per the news today, AU National Cabinet endorsed below National Vaccination Policy for Covid-19

https://www.health.gov.au/sites/default/files/documents/2020/11/australian-covid-19-vaccination-policy.pdf

An informative doc, easy to understand. Great info for the average citizen to see the AU vaccine agreements made, how many doses, what type + what target groups each vaccine is for and likely timelines. And only 17pages (unlike the US CDC 100+page 'interim' policy + planning doc)

No specific mention about AU vaccine related testing (however there should be some detail in the next future doc "Australian Government COVID-19 Implementation Plan" (which will now be developed with all states + territories).

Specific R&Rs mentioned in policy doc that should involve tests (PCR or RDTs or both?):
"The vaccines will be provisionally registered...on the basis of clinical data, with subsequent rolling review of additional clinical data as they become available with the aim to achieve full registration as soon as possible. The TGA will actively and comprehensively monitor any COVID-19 vaccines for safety after they are supplied.."

"...data collection and reporting requirements and adverse event monitoring via the TGA."

"The TGA has developed a COVID-19 Vaccine Pharmacovigilance Plan that builds on its already well-established Adverse Events Monitoring System (AEMS) by improving capacity and capability for adverse event reporting to the TGA by state and territory health departments, expanding active surveillance systems for COVID-19 vaccines"

"In addition to the TGA safety monitoring, the Australian Government funds an active safety, surveillance and monitoring system called AusVaxSafety.

"Pharmacovigilance is defined by the World Health Organization as the science and activity related to detecting, assessing, understanding and preventing adverse effects and other medicine related problems.Monitoring for adverse events following the COVID-19 will be important for clinician and consumer safety and confidence in the vaccination program."

(not being immunised successfully by a fast-tracked vaccine OR losing immunity over time = also an adverse event that the gov + pharma will have to check for & try avoiding..literally, we need time to pass to keep checking if it still works..no way to do a time-based survey in a lab...so requires mass pop survey testing long term ~2-3yrs post-vaccine? PCR or RDTs or both in conjunction? More info should be available once we know a successful vaccine candidate's characteristics + country plans)